Valuation RaySearch Laboratories AB OTC Markets
Stocks
RSLBF
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
OTC Markets
15:23:55 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 17.74 USD | +7.52% |
|
+7.52% | -25.46% |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 6,229 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -20.3% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,395 | 6,262 | 6,065 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -18.05% | -2.08% | -3.15% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 23.7x | 19.1x | 16.7x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 7.18x | 6.02x | 4.95x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.4x | 0.8x | 1.2x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.51x | 3.86x | 3.41x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.63x | 3.88x | 3.32x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 10.1x | 8.55x | 7.13x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 18.6x | 14.8x | 11.4x |
| EV / FCF | 234x | - | - | - | 21.7x | 36.5x | 23.1x | 17.4x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.74% | 4.33% | 5.74% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.5 | 5.55 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.16% | 2.43% | 3% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.805 | 9.7 | 11.1 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 51.2% | 46.4% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,382 | 1,614 | 1,827 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 631.5 | 732.5 | 850.5 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 344.5 | 423.5 | 530 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 265.5 | 328 | 412 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 166 | 33 | -164 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 185.30 | 185.30 | 185.30 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 33,618 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.9x | 5.76x | 22.06x | 0.28% | 245B | ||
| 37.02x | 6.61x | 20.93x | 0.65% | 154B | ||
| 44.64x | 11.9x | 26.26x | -.--% | 146B | ||
| 15.72x | 3.26x | 10.63x | -.--% | 60.26B | ||
| 34.5x | 6.77x | 21.5x | -.--% | 49.44B | ||
| 32.93x | 6.52x | 22.13x | 0.61% | 47.67B | ||
| 18.96x | 2.31x | 11.7x | 2.66% | 48.04B | ||
| 43.25x | 10.48x | 23.1x | -.--% | 45.74B | ||
| 76.33x | 7.23x | 22.01x | -.--% | 42.84B | ||
| Average | 37.36x | 6.76x | 20.04x | 0.47% | 93.2B | |
| Weighted average by Cap. | 36.55x | 7.04x | 21.20x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- RSLBF Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
















